Author
Listed:
- Christopher C. Stobart
(Emory University School of Medicine
Children’s Healthcare of Atlanta
Present address: Department of Biological Sciences, Butler University, Indianapolis, Indiana 46208, USA)
- Christina A. Rostad
(Emory University School of Medicine
Children’s Healthcare of Atlanta)
- Zunlong Ke
(School of Biology, Georgia Institute of Technology)
- Rebecca S. Dillard
(Emory University School of Medicine
Children’s Healthcare of Atlanta)
- Cheri M. Hampton
(Emory University School of Medicine
Children’s Healthcare of Atlanta)
- Joshua D. Strauss
(Emory University School of Medicine
Children’s Healthcare of Atlanta)
- Hong Yi
(Robert P Apkarian Integrated Electron Microscopy Core, Emory University)
- Anne L. Hotard
(Emory University School of Medicine
Children’s Healthcare of Atlanta
Present address: Viral Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, Georgia 30329, USA)
- Jia Meng
(Emory University School of Medicine
Children’s Healthcare of Atlanta
Present address: Alios BioPharma, Inc., South San Francisco, California 94080, USA)
- Raymond J. Pickles
(University of North Carolina)
- Kaori Sakamoto
(College of Veterinary Medicine, University of Georgia)
- Sujin Lee
(Emory University School of Medicine
Children’s Healthcare of Atlanta)
- Michael G. Currier
(Emory University School of Medicine
Children’s Healthcare of Atlanta)
- Syed M. Moin
(Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health)
- Barney S. Graham
(Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health)
- Marina S. Boukhvalova
(Sigmovir Biosystems Inc.)
- Brian E. Gilbert
(Baylor College of Medicine)
- Jorge C. G. Blanco
(Sigmovir Biosystems Inc.)
- Pedro A. Piedra
(Baylor College of Medicine
Baylor College of Medicine)
- Elizabeth R. Wright
(Emory University School of Medicine
Children’s Healthcare of Atlanta
Robert P Apkarian Integrated Electron Microscopy Core, Emory University)
- Martin L. Moore
(Emory University School of Medicine
Children’s Healthcare of Atlanta)
Abstract
Respiratory syncytial virus (RSV) is a leading cause of infant hospitalization and there remains no pediatric vaccine. RSV live-attenuated vaccines (LAVs) have a history of safe testing in infants; however, achieving an effective balance of attenuation and immunogenicity has proven challenging. Here we seek to engineer an RSV LAV with enhanced immunogenicity. Genetic mapping identifies strain line 19 fusion (F) protein residues that correlate with pre-fusion antigen maintenance by ELISA and thermal stability of infectivity in live RSV. We generate a LAV candidate named OE4 which expresses line 19F and is attenuated by codon-deoptimization of non-structural (NS1 and NS2) genes, deletion of the small hydrophobic (SH) gene, codon-deoptimization of the attachment (G) gene and ablation of the secreted form of G. OE4 (RSV-A2-dNS1-dNS2-ΔSH-dGm-Gsnull-line19F) exhibits elevated pre-fusion antigen levels, thermal stability, immunogenicity, and efficacy despite heavy attenuation in the upper and lower airways of cotton rats.
Suggested Citation
Christopher C. Stobart & Christina A. Rostad & Zunlong Ke & Rebecca S. Dillard & Cheri M. Hampton & Joshua D. Strauss & Hong Yi & Anne L. Hotard & Jia Meng & Raymond J. Pickles & Kaori Sakamoto & Suji, 2016.
"A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation,"
Nature Communications, Nature, vol. 7(1), pages 1-12, December.
Handle:
RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms13916
DOI: 10.1038/ncomms13916
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Sonal V. Gidwani & Devarshi Brahmbhatt & Aaron Zomback & Mamie Bassie & Jennifer Martinez & Jian Zhuang & John Schulze & Jason S. McLellan & Roberto Mariani & Peter Alff & Daniela Frasca & Bonnie B. B, 2024.
"Engineered dityrosine-bonding of the RSV prefusion F protein imparts stability and potency advantages,"
Nature Communications, Nature, vol. 15(1), pages 1-14, December.
- Bryan S. Sibert & Joseph Y. Kim & Jie E. Yang & Zunlong Ke & Christopher C. Stobart & Martin L. Moore & Elizabeth R. Wright, 2024.
"Assembly of respiratory syncytial virus matrix protein lattice and its coordination with fusion glycoprotein trimers,"
Nature Communications, Nature, vol. 15(1), pages 1-13, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms13916. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.